Skip to content

Author

R. Haumschild

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Editorial Oct 2026

Value-based care contracting for pharmacy drugs: opportunity for the United States.

The onset of improved data interoperability required as a result of the 21st Century Cures Act, 92% Health Information Exchange coverage, and lessons learned from European pharmaceutical risk-sharing models present innovative and timely opportunities for the U.S. to adopt pharmaceutical value-based contracting (VBC), w...

Urvisha Jain, Srinidhi Polkampally, Arnav Ajay Jadav et al. · 0 citations
Review Open access Oct 2026

AMCP Market Insights: Managed care approaches to ESR1-mutated advanced breast cancer.

A mutation in the estrogen receptor alpha gene (ESR1m) following first-line treatment with endocrine therapy in hormone receptor-positive metastatic breast cancer occurs in nearly half of patients. Detection of this mutation prior to radiologic progression using circulating tumor DNA (ctDNA)-based monitoring is an emer...

Bridget M. Flavin, C. Tweed, J. Evans et al. · 0 citations
Open access Oct 2026

Integrating ctDNA-based ESR1m monitoring into first-line care for ER+, HER2− advanced breast cancer: a consensus workflow

Practical, experience-informed considerations are supplemented by an opinion-based consensus workflow model designed to provide clinicians with a flexible framework for implementing ctDNA-based ESR1m monitoring during first-line care for ER+, HER2– aBC.

Y. Abdou, Amber Cipriani, Trevor Feinstein et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.